Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney

  • Interventions for lowering plasma homocysteine levels in dialysis patients

    Cochrane Database of Systematic Reviews Date published:

  • Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials

    The Lancet Date published:

  • Proteinuria and Stroke: A Meta-analysis of Cohort Studies

    American Journal of Kidney Diseases Date published:

  • EFFECT OF HOMOCYSTEINE LOWERING ON CLINICAL OUTCOMES IN PEOPLE WITH KIDNEY DISEASE: A META-ANALYSIS

    Date published:

  • ASPIRIN BENEFIT INCREASES WITH DECLINING RENAL FUNCTION AMONG PEOPLE WITH HYPERTENSION

    Date published:

  • BLOOD PRESSURE LOWERING REDUCES CARDIOVASCULAR EVENTS AND MORTALITY IN DIALYSIS PATIENTS: A SYSTEMATIC REVIEW OF RANDOMISED CONTROLLED TRIALS

    Date published:

  • USE OF HIGH CUT-OFF HAEMODIALYSIS IN A PATIENT WITH MULTIPLE MYELOMA AND SIGNIFICANT CAST NEPHROPATHY: A CASE REPORT

    Nephrology Date published:

  • Lipid lowering in chronic kidney disease

    Therapeutic Strategies in Lipid Disorders Date published:

  • Photopheresis therapy for problematic renal allograft rejection

    Journal of Clinical Apheresis Date published:

  • The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis

    PLOS Medicine Date published:

  • TWENTY YEAR CANCER OUTCOMES OF A RANDOMISED TRIAL OF IMMUNOSUPPRESSION IN KIDNEY TRANSPLANT RECIPIENTS: RESULTS OF THE AUSTRALIAN MULTICENTRE TRIAL OF CYCLOSPORINE WITHDRAWAL

    Transplantation Date published:

  • Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial

    Kidney International Date published:

  • TWENTY YEAR CANCER OUTCOMES OF A RANDOMIZED TRIAL OF IMMUNOSUPPRESSION IN KIDNEY TRANSPLANT RECIPIENTS: RESULTS OF THE AUSTRALIAN MULTICENTRE TRIAL OF CYCLOSPORINE WITHDRAWAL

    Date published:

  • INDEPENDENT IMPACT OF ALBUMINURIA AND KIDNEY FUNCTION ON CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE TRIAL

    Date published:

  • Chronic Kidney Disease, Cardiovascular Events, and the Effects of Perindopril-Based Blood Pressure Lowering

    Journal of the American Society of Nephrology Date published:

  • 20 year outcomes of the Australian multicentre randomised trial of cyclosporine withdrawal in renal transplantation.

    Date published: